LEAD BAMZIREOTIDE NAVOXETAN PB-212
UNII D2A42X3LCS

Substance Identification & Data

This profile provides standardized clinical and technical data for Lead Bamzireotide Navoxetan Pb-212, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D2A42X3LCS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2941523-47-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D2A42X3LCS

CAS Registry Number

2941523-47-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEAD BAMZIREOTIDE NAVOXETAN PB-212

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C72H104N16O20S2.Pb

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QGVGTCHMAGOYCL-BYUNHRDPSA-L

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C211711

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

172866335

Unique identification number in the NCBI database of chemical substances.

INN ID

13292

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1[C@@H](C(=O)N[C@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](CSSC[C@@H](C(N[C@H](C1=O)Cc2ccc(O)cc2)=O)NC([C@@H](Cc3ccccc3)NC(=O)CCOCCOCCNC(CN4CCN(CCN(CCN(CC(=O)[O-])CC4)CC(N)=O)CC(=O)[O-])=O)=O)C(N[C@@H]([C@@H](C)O)CO)=O)=O)=O)CCCCN)Cc5c[nH]c6ccccc56.[212Pb+2]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lead Bamzireotide Navoxetan Pb-212. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LEAD (212PB) BAMZIREOTIDE NAVOXETAN

Common Names & Synonyms

LEAD (212PB) BAMZIREOTIDE NAVOXETAN [INN]

LEAD BAMZIREOTIDE NAVOXETAN PB-212

LEAD-212PB, (N-(3-(2-(2-((2-(7-(2-AMINO-2-(OXO-.KAPPA.O)ETHYL)-4,10-BIS((CARBOXY-.KAPPA.O)METHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10)ACETYL-.KAPPA.O)AMINO)ETHOXY)ETHOXY)-1-OXOPROPYL)-D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-N-((1R,2R)-2-HYDROXY-1-(HYDROXYMETHYL)PROPYL)-L-CYSTEINAMIDE CYCLIC (2->7)-DISULFIDATO(2-))-

External Clinical & Regulatory Resources

Previous UNIID2A3XL838T

Next UNIID2A4V58Y43